rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Lite Strategy, Inc.

LITS · Nasdaq

Health CareBiotechnologyJust started moving

LITS stood above a rising 150-day average in 3 of the last 52 weekly readings, including each of the last 3 weeks. It is 7.8% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
3 in a row
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$164K
Insider sales, 12 months
$946K
Officials’ trades on record
0
Institutions holding
33 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$909K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3
Sale orders, 12 months1
Buyers · sellers1 · 1
WhoDidSharesTraded
James P. FlynnDirectorbought25,000at $0.855524 Jun 2026filed 25 Jun 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders33-2 on the quarter
New · exited4 · 5
Reported value$5.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 20261,247,350$1.2M-497,350−28.5%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20261,021,892$942K-21,421−2.1%
RLH Capital LLCnew · filed 10 Aug 2026806,433$744K+806,433
TWO SIGMA INVESTMENTS, LPreduced · filed 14 Aug 2026557,011$514K-57,431−9.3%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026365,019$337K-36,072−9.0%
CITADEL ADVISORS LLCreduced · filed 14 Aug 2026357,529$330K-372,570−51.0%
BlackRock, Inc.added · filed 7 Aug 2026275,829$254K+117,938+74.7%
MARSHALL WACE, LLPreduced · filed 13 Aug 2026232,979$214K-100,529−30.1%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026195,392$180K+1,397+0.7%
JANE STREET GROUP, LLCadded · filed 14 Aug 2026192,627$178K+135,381+236.5%
30 Jun 2023 – 30 Jun 2026
243444Jun 23Mar 24Dec 24Sep 25Jun 26

Everyone who traded it

James P. Flynn Company insiderDirector · last 24 Jun 20263 · 0
Justin J. File Company insiderCEO, CFO and Secretary · last 12 Feb 20260 · 0
Alexander Schornstein Company insider10% owner · last 18 Dec 20250 · 1
Frederick W. Driscoll Company insiderDirector · last 14 Nov 20251 · 1
Joshua Riezman Company insiderDirector · last 14 Nov 20250 · 0
Nicholas Glover Company insiderDirector · last 14 Nov 20250 · 0
Charles Benjamin Lee Company insiderDirector · last 3 Oct 20250 · 0
Steven D. Wood Company insiderDirector · last 15 Jul 20250 · 0
Thomas C. Reynolds Company insiderDirector · last 15 Jul 20251 · 0
Funicular Funds, Lp Company insider10% owner · last 20 Oct 20230 · 0
Moez Kassam Company insider10% owner · last 20 Oct 20232 · 0
Anson Funds Management Lp Company insider10% owner · last 11 Oct 20230 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2026 · to 30 Jun 2026-160%
Share count trendFY 2026 · to 22 Sep 2026-6.2%
Cash and equivalentsFY 2026 · to 30 Jun 2026$5.7M

Analyst forecasts

No analyst forecasts yet.